Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD
NCT ID: NCT01118650
Last Updated: 2012-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2010-06-30
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
NCT05469386
Effectiveness of the Quotient® ADHD Assessment in a System of Care
NCT02094612
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
NCT00179894
Adult Normative Performance of the Quotient ADHD System
NCT01308450
Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
NCT00711724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children previously identified and currently receiving an Individualized Education Program (IEP) or 504 accommodations in the classroom setting for symptoms of ADHD.
Open enrollment of 30 subjects, both male and female.
One study visit in which subjects will perform/receive the following assessments/evaluations:
1. Quotient ADHD System Test
2. Vanderbilt ADHD Diagnostic Teacher Rating Scale
3. Vanderbilt ADHD Diagnostic Parent Rating Scale
The primary analytical goal is to examine the extent of agreement of the Quotient ADHD System(either individual measures or in combination) with standard measures (Vanderbilt ADHD Diagnostic Teacher Rating Scale and Vanderbilt ADHD Diagnostic Parent Rating Scale) and to compare this agreement with that seen between the standard measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 8 through 14 years old at time of enrollment.
* Pre-identified as receiving an Individualized Education Program (IEP) or 504 accommodations for symptoms of ADHD in the school setting by the Special Education Coordinator in the school district.
* A parent/guardian of the child must be willing to participate.
8 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New Hampshire School Administrative Unit #44
UNKNOWN
BioBehavioral Diagnostics Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Calvin R Sumner, MD
Role: PRINCIPAL_INVESTIGATOR
BioBehavioral Diagnostic Company
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBD0108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.